Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis

NCT05057052 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Liver Metastases
Colorectal Cancer Metastatic

Interventions

DRUG: Sintilimab
DRUG: Regorafenib
COMBINATION_PRODUCT: US/CT-guided Percutaneous Cryoablation

Sponsor

Fudan University